Crossmark

De-escalation from Dose-Intensified Anti-TNF Therapy Is Successful in the Majority of IBD Patients at 12 Months

Published Online: 2021-03-25

Published Print: 2022-01

Authors

Little, Robert D.

Chu, Isabel E.

Ward, Mark G.

Sparrow, Miles P.
License Information

Text and Data Mining valid from 2021-03-25

Version of Record valid from 2021-03-25
More Information

Article History

Received: 17 August 2020

Accepted: 16 January 2021

First Online: 25 March 2021

Declarations

:

: The authors declare that they have no financial conflict of interest.

Document is current